- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01995890
Effect of Nepafenac Eye Drops on Intraocular Pressure in Normal Eyes
November 22, 2013 updated by: Dr T V Patel Eye Institute
Effect of Nepafenac Eye Drops on Intraocular Pressure - a Randomized Prospective Study
The Nevanac product information insert says that it can cause increase in eye pressure in 5-10% of patients.
There is very little published literature on the effect of topical Nepafenac eye drops on eye pressure in normal people.
The purpose of our study is to report this effect with a working hypothesis that there is no increase in eye pressure following use of Nepafenac eye drops.
Study Overview
Study Type
Interventional
Enrollment (Actual)
327
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Gujarat
-
Vadodara, Gujarat, India, 390001
- Dr TV Patel Eye Insititute
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Best corrected visual acuity better than 20/80 in both eyes
- Intraocular pressure ≤21 mmHg in both eyes
- Open angles on 4 mirror gonioscopy without indentation
- Normal optic disc on stereoscopic examination and photographs
Exclusion Criteria:
- Change in the systemic medication profile during the course of the study
- Allergy to nepafenac molecule
- Corneal thinning/corneal infections
- Any intraocular surgery in past 3 months
- Pregnancy or those planning to conceive
- Breast feeding patients
- Unwillingness to participate in the trial
- Concomitant use of any other ocular drug (except artificial tears)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: nepafenac
Nepafenac 0.1% eye drops, 3 times a day
|
Other Names:
|
No Intervention: control
No intervention in the control arm
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Intraocular pressure
Time Frame: 4 weeks
|
Intraocular pressure elevation of more than 4 mmHg from baseline
|
4 weeks
|
Intraocular pressure
Time Frame: 8 weeks
|
Intraocular pressure elevation of more than 4 mmHg from baseline
|
8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Paaraj R Dave, MD, TV Patel Eye Institute
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Gamache DA, Graff G, Brady MT, Spellman JM, Yanni JM. Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: I. Assessment of anti-inflammatory efficacy. Inflammation. 2000 Aug;24(4):357-70. doi: 10.1023/a:1007049015148.
- Chiba T, Kashiwagi K, Chiba N, Tsukahara S. Effect of non-steroidal anti-inflammatory ophthalmic solution on intraocular pressure reduction by latanoprost in patients with primary open angle glaucoma or ocular hypertension. Br J Ophthalmol. 2006 Mar;90(3):314-7. doi: 10.1136/bjo.2005.080895.
- Warren KA, Fox JE. Topical nepafenac as an alternate treatment for cystoid macular edema in steroid responsive patients. Retina. 2008 Nov-Dec;28(10):1427-34. doi: 10.1097/IAE.0b013e31817e7ead.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2012
Primary Completion (Actual)
February 1, 2013
Study Completion (Actual)
April 1, 2013
Study Registration Dates
First Submitted
November 22, 2013
First Submitted That Met QC Criteria
November 22, 2013
First Posted (Estimate)
November 27, 2013
Study Record Updates
Last Update Posted (Estimate)
November 27, 2013
Last Update Submitted That Met QC Criteria
November 22, 2013
Last Verified
November 1, 2013
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- TVPEI
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intraocular Pressure
-
University of PittsburghRecruiting
-
The University of Hong KongCompleted
-
Rajiv Gandhi Cancer Institute & Research Center...CompletedIntraocular PressureIndia
-
Prince of Songkla UniversityCompletedIntraocular PressureThailand
-
Astellas Pharma IncCompletedIntraocular PressureUnited States
-
First Affiliated Hospital, Sun Yat-Sen UniversityUnknown
-
Icare Finland OyCompleted
-
Iladevi Cataract and IOL Research CenterCompleted
Clinical Trials on nepafenac
-
Jaeb Center for Health ResearchNational Eye Institute (NEI)CompletedDiabetic Macular EdemaUnited States
-
Actavis Inc.Completed
-
Alcon ResearchTerminated
-
Alcon ResearchCompleted
-
Melissa ToyosBausch & Lomb IncorporatedCompletedInflammation | Cataract | Retinal EdemaUnited States
-
Alcon ResearchCompletedEpiretinal MembraneUnited States
-
Intuor Technologies, Inc.CompletedCystoid Macular Edema
-
Universiti Sains MalaysiaCompleted